Lung cancer screening
The industry’s most comprehensive approach to low dose lung cancer screening
Most SOMATOM computed tomography (CT) and Biograph PET/CT systems are now indicated for low dose lung cancer screening. Siemens offers the industry’s most comprehensive approach to low dose lung cancer screening. This is enabled on most of Siemens’ new CT and PET/CT scanners as well as on the company’s installed base of non-end-of-support scanners, using the standard low-dose lung protocol.*
PET/CT scanning is already a critical tool to help physicians detect and stage lung cancer to determine the appropriate treatment and monitor therapy response. Now Siemens latest PET/CT scanners can be leveraged as a shared service model to support screening efforts to drive operational efficiencies to reduce patient wait times and enable scheduling flexibility— ultimately to improve patient outcomes and support additional downstream revenue streams.
The protocol meets the Centers for Medicare and Medicaid Services (CMS) technical requirements for lung cancer screening, “[the facility must perform] LDCT with volumetric CT dose index (CTDIvol) of ≤3.0 mGy (milliGray) for standard size patients (defined to be 5’ 7” and approximately 155 pounds) with appropriate reductions in CTDIvol for smaller patients and appropriate increases in CTDIvol for larger patients .”1
1 Centers for Medicare and Medicaid Services. Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N). Feb. 5, 2015. Online: https://www.cms.gov/Medicare/Medicare-General-Information/MedicareApprovedFacilitie/Lung-Cancer-Screening-Registries.html
*Indication for low dose lung cancer screening is applicable to the following scanner models: SOMATOM Force, SOMATOM Definition Flash, SOMATOM Definition Edge, SOMATOM Definition AS/AS+, SOMATOM Perspective, SOMATOM Scope, SOMATOM Emotion 16, Biograph mCT, Biograph mCT Flow and Biograph Horizon..